Written by Keith Noonan for The Motley Fool ->
Teva posted its Q2 results this week, reporting an earnings miss even though sales beat expectations.
The company's forward guidance didn't deliver big
NA
Nasdaq News
2 Aug 2026 3 days ago 1 min read
Nasdaq News โ 2 August 2026
Text:
18 0 0
๐ Translate:
๐๏ธ AI Podcast โ Two-Host Discussion
Why Teva Pharmaceutical Stock Surged This Week
Kokoro TTS ยท ~5 min episode ยท American English voices
Choose voices for Host A and Host B. Changes take effect on next play.
A
Now Speaking
โ
Generating podcastโฆ
Synthesising speech โ will play automatically when readyโฆ
0:00 / 0:00
Teva posted its Q2 results this week, reporting an earnings miss even though sales beat expectations.